Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a supplement curb your appetite? small study says maybe

NCT ID NCT07597382

Symptom relief Sponsor: OmniSolutions Laboratory Holdings Limited Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether a dietary supplement called NatureU Burn, made from African mango seed extract and inulin, can increase feelings of fullness after a sugary drink. Fourteen healthy adults took either glucose alone or glucose plus the supplement, then rated their fullness and hunger over four hours. The goal was to see if the supplement could help control appetite, which might be useful for weight management.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
NatureU Burn (Irvingia gabonensis seed extract and inulin)
What this could lead to
If it works, this supplement could help people feel fuller after meals, which may aid in weight management.
What could go wrong
This was a very small, early study in healthy adults, not people with obesity. Results may not apply to the general population, and the supplement's long-term effects are unknown.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

14 people

The number who actually took part.

Started

Apr 2024

Finished

May 2024

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 50 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Healthy adults aged 18 to 50 years. * Male or female participants. * Body mass index within the normal range of 18.5 to 23.9 kg/m2. * Regular habit of eating breakfast. * Able to fast for at least 10 hours after dinner. * Signed informed consent before enrollment. Exclusion Criteria: * Pregnant or breastfeeding women. * Individuals engaged in heavy physical labor or high-intensity exercise. * Chronic sleep deprivation during the previous 3 months. * Self-reported body weight increase or decrease of at least 4 kg during the previous 3 months. * Current use of weight-loss medications. * Special dietary patterns, such as low-carbohydrate diet or intermittent fasting. * Abnormal eating attitude based on eating attitude assessment. * Serious cardiovascular, hepatic, renal, gastrointestinal, hematologic, or neurologic dysfunction. * History of bariatric surgery. * Major surgery or hospitalization within the previous 3 months. * Eating disorders, including binge eating disorder, anorexia nervosa, or bulimia nervosa. * Abnormal glucose metabolism or lipid metabolism. * Intolerance or allergy to the test foods. * Excessive smoking, defined as more than 15 cigarettes per day. * Alcohol consumption greater than 15 g alcohol per day.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Appetite are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Lipid Metabolism Disorders Obesity obesity disorder Overweight

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Appetite Fat disorder Food intake Obesity & overweight Satiety

Contacts and locations

Locations

  • Dao County People's Hospital

    Yongzhou, Hunan, 425300, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.